Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 11 studies | 30% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 7458.42 | 1445 / 1445 | 100% | 6.66 | 183 / 183 |
prostate | 100% | 7564.58 | 245 / 245 | 100% | 4.61 | 502 / 502 |
brain | 100% | 12379.19 | 2641 / 2642 | 100% | 11.01 | 704 / 705 |
intestine | 100% | 7089.21 | 966 / 966 | 100% | 4.32 | 526 / 527 |
bladder | 100% | 5638.14 | 21 / 21 | 100% | 4.77 | 503 / 504 |
uterus | 100% | 5550.82 | 170 / 170 | 100% | 5.90 | 458 / 459 |
adrenal gland | 100% | 8350.93 | 258 / 258 | 100% | 11.84 | 229 / 230 |
ovary | 100% | 7179.97 | 180 / 180 | 99% | 3.59 | 427 / 430 |
stomach | 100% | 4704.69 | 358 / 359 | 99% | 4.01 | 284 / 286 |
breast | 100% | 10258.58 | 459 / 459 | 99% | 4.56 | 1106 / 1118 |
lung | 100% | 10264.31 | 578 / 578 | 99% | 4.47 | 1142 / 1155 |
thymus | 100% | 7473.22 | 652 / 653 | 99% | 3.65 | 599 / 605 |
pancreas | 98% | 3689.43 | 321 / 328 | 99% | 5.28 | 176 / 178 |
skin | 96% | 11259.51 | 1732 / 1809 | 99% | 3.94 | 469 / 472 |
kidney | 98% | 3792.06 | 87 / 89 | 90% | 2.86 | 807 / 901 |
adipose | 100% | 8979.92 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 6.99 | 29 / 29 |
spleen | 100% | 7321.18 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 4.96 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.59 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 99% | 3.36 | 79 / 80 |
heart | 97% | 3877.24 | 836 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 96% | 3254.28 | 1275 / 1335 | 0% | 0 | 0 / 0 |
muscle | 95% | 4016.62 | 764 / 803 | 0% | 0 | 0 / 0 |
liver | 26% | 1242.13 | 58 / 226 | 60% | 1.31 | 244 / 406 |
peripheral blood | 74% | 5200.60 | 687 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007265 | Biological process | Ras protein signal transduction |
GO_0005903 | Cellular component | brush border |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0005634 | Cellular component | nucleus |
GO_0030695 | Molecular function | GTPase regulator activity |
GO_0005085 | Molecular function | guanyl-nucleotide exchange factor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | RALGDS |
Protein name | Ral guanine nucleotide dissociation stimulator FLJ00185 protein (Ral guanine nucleotide dissociation stimulator, isoform CRA_b) Ral guanine nucleotide dissociation stimulator (RalGDS) (Ral guanine nucleotide exchange factor) (RalGEF) |
Synonyms | KIAA1308 hCG_31468 FLJ00185 RGF |
Description | FUNCTION: Functions as a guanine nucleotide exchange factor (GEF) activating either RalA or RalB GTPases and plays an important role in intracellular transport. Interacts and acts as an effector molecule for R-Ras, H-Ras, K-Ras, and Rap (By similarity). During bacterial clearance, recognizes 'Lys-33'-linked polyubiquitinated TRAF3 and subsequently mediates assembly of the exocyst complex . . |
Accessions | ENST00000477660.1 Q12967 A0A2R8YE90 Q9HAY0 ENST00000424572.1 ENST00000460587.1 ENST00000372062.8 [Q12967-4] Q9HAX9 Q5T7U6 ENST00000372047.7 [Q12967-6] ENST00000393157.8 [Q12967-5] ENST00000393160.7 [Q12967-3] Q9HAX8 A0A2R8YEX4 ENST00000372050.8 [Q12967-1] Q8TEK9 |